Charles River Laboratories International, Inc.

NYSE

Market Cap.

8.16B

Avg. Volume

743.84K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. News

Charles River Laboratories International, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Diagnostics & Research
criver.com

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Charles River Laboratories International, Inc. Earnings & Revenue

Charles River Laboratories International, Inc. Financials

Table Compare

Compare CRL metrics with:

   

Earnings & Growth

CRL

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

CRL

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

CRL

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

CRL

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Charles River Laboratories International, Inc. Income

Charles River Laboratories International, Inc. Balance Sheet

Charles River Laboratories International, Inc. Cash Flow

Charles River Laboratories International, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Charles River Laboratories International, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Charles River Laboratories International, Inc. Executives

NameRole
Mr. James C. Foster J.D.Chief Executive Officer, President & Chairman
Ms. Flavia H. PeaseCorporate Executive Vice President & Chief Financial Officer
Ms. Birgit GirshickCorporate Executive Vice President & Chief Operating Officer
Mr. Joseph W. LaPlume J.D.Corporate Executive Vice President of Corporate Development & Strategy
Mr. Todd SpencerCorporate Vice President of Investor Relations
NameRoleGenderDate of BirthPay
Mr. James C. Foster J.D.Chief Executive Officer, President & ChairmanMale19512.66M
Ms. Flavia H. PeaseCorporate Executive Vice President & Chief Financial OfficerFemale19731.66M
Ms. Birgit GirshickCorporate Executive Vice President & Chief Operating OfficerFemale19701.28M
Mr. Joseph W. LaPlume J.D.Corporate Executive Vice President of Corporate Development & StrategyMale1974928.36K
Mr. Todd SpencerCorporate Vice President of Investor RelationsMale

--

Charles River Laboratories International, Inc. Insider Trades

Date31 Jan
NamePease Flavia
RoleCorporate Executive VP & CFO
TransactionAcquired
TypeA-Award
Shares2704
Date31 Jan
NamePease Flavia
RoleCorporate Executive VP & CFO
TransactionDisposed
TypeF-InKind
Shares914
Date31 Jan
NameFOSTER JAMES C
RoleChairman, President and CEO
TransactionAcquired
TypeA-Award
Shares19608
Date31 Jan
NameFOSTER JAMES C
RoleChairman, President and CEO
TransactionDisposed
TypeF-InKind
Shares6827
Date31 Jan
NameLaPlume Joseph W
RoleEVP, Corp Strategy & Develop
TransactionAcquired
TypeA-Award
Shares2738
DateNameRoleTransactionTypeShares
31 JanPease FlaviaCorporate Executive VP & CFOAcquiredA-Award2704
31 JanPease FlaviaCorporate Executive VP & CFODisposedF-InKind914
31 JanFOSTER JAMES CChairman, President and CEOAcquiredA-Award19608
31 JanFOSTER JAMES CChairman, President and CEODisposedF-InKind6827
31 JanLaPlume Joseph WEVP, Corp Strategy & DevelopAcquiredA-Award2738

Discover More

Streamlined Academy

Charles River Laboratories International, Inc.

NYSE

Market Cap.

8.16B

Avg. Volume

743.84K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Charles River Laboratories International, Inc. News

Charles River Laboratories International, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Charles River Laboratories International, Inc. Earnings & Revenue

Charles River Laboratories International, Inc. Income

Charles River Laboratories International, Inc. Balance Sheet

Charles River Laboratories International, Inc. Cash Flow

Charles River Laboratories International, Inc. Financials Over Time

Charles River Laboratories International, Inc. Executives

NameRole
Mr. James C. Foster J.D.Chief Executive Officer, President & Chairman
Ms. Flavia H. PeaseCorporate Executive Vice President & Chief Financial Officer
Ms. Birgit GirshickCorporate Executive Vice President & Chief Operating Officer
Mr. Joseph W. LaPlume J.D.Corporate Executive Vice President of Corporate Development & Strategy
Mr. Todd SpencerCorporate Vice President of Investor Relations
NameRoleGenderDate of BirthPay
Mr. James C. Foster J.D.Chief Executive Officer, President & ChairmanMale19512.66M
Ms. Flavia H. PeaseCorporate Executive Vice President & Chief Financial OfficerFemale19731.66M
Ms. Birgit GirshickCorporate Executive Vice President & Chief Operating OfficerFemale19701.28M
Mr. Joseph W. LaPlume J.D.Corporate Executive Vice President of Corporate Development & StrategyMale1974928.36K
Mr. Todd SpencerCorporate Vice President of Investor RelationsMale

--

Charles River Laboratories International, Inc. Insider Trades

Date31 Jan
NamePease Flavia
RoleCorporate Executive VP & CFO
TransactionAcquired
TypeA-Award
Shares2704
Date31 Jan
NamePease Flavia
RoleCorporate Executive VP & CFO
TransactionDisposed
TypeF-InKind
Shares914
Date31 Jan
NameFOSTER JAMES C
RoleChairman, President and CEO
TransactionAcquired
TypeA-Award
Shares19608
Date31 Jan
NameFOSTER JAMES C
RoleChairman, President and CEO
TransactionDisposed
TypeF-InKind
Shares6827
Date31 Jan
NameLaPlume Joseph W
RoleEVP, Corp Strategy & Develop
TransactionAcquired
TypeA-Award
Shares2738
DateNameRoleTransactionTypeShares
31 JanPease FlaviaCorporate Executive VP & CFOAcquiredA-Award2704
31 JanPease FlaviaCorporate Executive VP & CFODisposedF-InKind914
31 JanFOSTER JAMES CChairman, President and CEOAcquiredA-Award19608
31 JanFOSTER JAMES CChairman, President and CEODisposedF-InKind6827
31 JanLaPlume Joseph WEVP, Corp Strategy & DevelopAcquiredA-Award2738

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
criver.com

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. Financials

Table Compare

Compare CRL metrics with:

   

Earnings & Growth

CRL

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

CRL

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

CRL

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

CRL

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Charles River Laboratories International, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)